This factsheet provides basic information on sexually transmitted infections (STIs), and a snapshot on the global status of STIs in the context of HIV prevention and global health equity.
Sexually Transmitted Infections
An Introductory Fact Sheet
Doxycycline for STI Prevention: Evidence and Current Research
Friday, October 7, 2022
Very high STI prevalence is being observed globally. Doxycycline post-exposure prophylaxis (dPEP) has been proposed as an STI prevention strategy to reduce chlamydia, syphilis, and possibly gonorrhea, and trials are ongoing among cisgender gay and bisexual men as well as African cisgender women. Learn about the latest scientific data and more during this Choice Agenda webinar.
Featuring Dr. Connie Celum, Jennifer Mahn, Dr. Victor Omollo, Rodney Perkins and Dr. Jenell Stewart
AVAC’s Strategic Plan 2022-2026
AVAC’s strategic framework is grounded in a multi-layered approach that carefully considers all of the components needed to achieve the organization’s vision, capitalize on its key strengths, and ensure that AVAC is poised to make an impact on the issues it cares most about over the next five years, and beyond.
The vision describes the world we are striving for. The mission describes what AVAC does in service to achieving this vision. The strategic pillars outline the objectives and approaches that AVAC will take over the next five years to achieve its mission and vision. The strategic pillars are supported by AVAC’s core values—the principles by which we work—as well as a set of key enablers.
Advocate, Translate, Catalyze: For HIV prevention and health equity
In this document, we look at the actions we are taking and those that as a field we all need to take to transform prevention “options” developed through research into prevention “choices” for people that can save lives and help end epidemics. This work is critical, and it is shared – just as we developed our strategic plan and EDI statement in partnership with so many, so too will we move this work forward, together.
20 Essential Resources – Condoms & Family Planning
As recent-day family planning and reproductive health efforts place greater emphasis on innovation, it is important to remember the value of evidence-based family planning tools that have been effective for decades. Since the physical properties of condoms have not undergone substantial change, many people may forget the power of condoms as a family planning tool. This collection was created as a reminder to all of us that some methods continue to work even as innovations arise.
Future Prospects for New Vaccines Against Sexually Transmitted Infections
This review provides an update on the need, development status, and important next steps for advancing development of vaccines against sexually transmitted infections (STIs), including herpes simplex virus (HSV), Neisseria gonorrhoeae (gonorrhea), Chlamydia trachomatis (chlamydia), and Treponema pallidum (syphilis).
Vaccines Against Sexually Transmitted Infections: The way forward
This special issue of Vaccine summarizes a 2013 STI Vaccine Technical Consultation where participants outlined a roadmap for accelerating development and introduction of new STI vaccines. The issue provides details for critical action steps for each individual STI vaccine.
Available here.
Internal Condoms: A Tool To Advance Sexual and Reproductive Health and Rights for All
Internal condoms, previously called female condoms, are an important tool to advance sexual and reproductive health and rights (SRHR) for all. Internal condoms are currently the only non-hormonal multipurpose prevention method designed for and initiated by women and receptive sexual partners that provides effective protection against unintended pregnancy and STI acquisition, including HIV. This resource shares new data on the efficacy and importance of internal condoms, and includes critical new USAID condom procurement data that indicate the need for increased internal condom procurement by United States global health agencies and programs.
Advocating Female Condoms: A reflection on stakeholder commitments & trends in support for female condoms
Produced by the Universal Access to Female Condoms consortium, this document analyzes policies, programs and budgets of organizations working on female condoms; looks at trends in expenditures on female condoms; provides an overview of emerging trends relevant for female condom advocacy, programming and procurement; and formulates recommendations for the future of female condom advocacy.
Breaking Regulatory Barriers for Greater Female Condom Access
A variety of safe and effective female condoms currently exist. However, regulatory hurdles limit new products from entering consumer markets. With the pipeline of new receptive-partner initiated condoms growing, advocates must understand how regulatory issues determine product introduction and approval in their country.
Receptive partner-initiated condoms in development
Link between regulatory environment and female condom access
Current regulatory issues and obstacles
Unique advocacy opportunity to break barriers to existing female condoms and pave the way for emerging internal condoms
You can watch the webinar here.